PATENT CLAIM ANALYSIS

Application Number: 16107936
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["514", "04400A"]

Abstract:
This disclosure relates to methods and compositions for managing vascular conditions by targeting microRNA. In certain embodiments, the disclosure relates to antisense, RNA interference, and blocking oligonucleotide therapeutic compositions and uses related thereto.

Claim (Index 6):
The composition of  claim 1 , wherein the nucleobase polymer comprises 8, 9, 10, 15, 20, 30, 40, 50, 60, 70, 80, 90 or more nucleobases.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 96.0
- Lexical Diversity: 1.31034
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14433150', '13583963', '14561709', '15243604', '14474965']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7862008319130408
- 35 USC 102 Novelty (BERT): 0.5181837943093548
- Combined Prediction Score: 0.7593991281526722
- Mean Citation Score: 272.43902
- Max Citation Score: 277.95663
- Similarity Product: 174.11746547751903

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test